erythromycin 500 MG Oral Tablet
- RxCUI
- 197650
- RxNorm name
- erythromycin 500 MG Oral Tablet
- Display name
- erythromycin 500 MG Oral Tablet
- Full name
- erythromycin 500 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Erythromycin | ERYTHROMYCIN | Golden State Medical Supply, Inc. | 0c05e1f7-a3d4-8e69-e063-6394a90aecc3 | 2026-04-21 | Warnings, Adverse reactions | 197650 |
| Erythromycin | ERYTHROMYCIN | Torrent Pharmaceuticals Limited | 933049f6-61b9-4ed5-b6b7-60c5037e2115 | 2026-03-05 | Warnings, Adverse reactions | 197650 |
| ERYTHROMYCIN | ERYTHROMYCIN | Ascend Laboratories, LLC | 3b415e31-e5d4-4990-8021-78459af73372 | 2025-10-17 | Warnings, Adverse reactions | 197650 |
| Erythromycin | ERYTHROMYCIN | Teva Pharmaceuticals USA, Inc. | 75a0bd5a-d09f-483b-bfd8-f8343b149eb2 | 2024-08-01 | Warnings, Adverse reactions | 197650 |
| Erythromycin | ERYTHROMYCIN | Zydus Pharmaceuticals USA Inc. | 0277341c-8513-4317-9334-c242f97630c1 | 2024-03-20 | Warnings, Adverse reactions | 197650 |
| ERYTHROMYCIN | ERYTHROMYCIN | Nivagen Pharmaceuticals, Inc. | aa61cb37-5fc5-4225-b894-1d660386777f | 2024-01-09 | Warnings, Adverse reactions | 197650 |
| Erythromycin | ERYTHROMYCIN | Modavar Pharmaceuticals LLC | bc3d091b-1fc8-4f7a-a3c2-8ede87f5faa0 | 2023-12-23 | Warnings, Adverse reactions | 197650 |
| Erythromycin | ERYTHROMYCIN | Cadila Pharmaceuticals Limited | fae8fc38-3c60-43b8-a0f9-2c50df332505 | 2023-12-22 | Warnings, Adverse reactions | 197650 |
| Erythromycin | ERYTHROMYCIN | Alembic Pharmaceuticals Limited | 904b9ab6-9a2a-47f3-8a38-04920ce696e0 | 2023-08-29 | Warnings, Adverse reactions | 197650 |
| Erythromycin | ERYTHROMYCIN | Alembic Pharmaceuticals Inc. | 383f9011-a3e0-4d7d-b058-5f8ab319dc8c | 2023-08-25 | Warnings, Adverse reactions | 197650 |
| Erythromycin | ERYTHROMYCIN | Zydus Lifesciences Limited | 76608fdd-1248-4942-9518-fd8076244fa7 | 2023-06-21 | 197650 | |
| Erythromycin | ERYTHROMYCIN | Orange Pharmaceuticals USA LLC | 379ed8f7-b54f-495f-932e-cd0e4c691134 | 2021-07-05 | Warnings, Adverse reactions | 197650 |
| Erythromycin | ERYTHROMYCIN | Wilshire Pharmaceuticals | f2efbc94-64f7-4130-ab23-e5983854f730 | 2019-01-14 | Warnings, Adverse reactions | 197650 |
| Erythromycin | ERYTHROMYCIN | Arbor Pharmaceuticals, Inc. | ca1326d6-c5c6-4572-96b6-e56cd944799c | 2018-12-04 | Warnings, Adverse reactions | 197650 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 661ad77d-8f9f-4366-a3de-2dc3acb1850d | erythromycin 500 MG Oral Tablet | PSN | 22 | ERYTHROMYCIN TABLETS, USP | 20200117 |
| 661ad77d-8f9f-4366-a3de-2dc3acb1850d | erythromycin 500 MG Oral Tablet | SCD | 22 | ERYTHROMYCIN TABLETS, USP | 20200117 |
| ca1326d6-c5c6-4572-96b6-e56cd944799c | erythromycin 500 MG Oral Tablet | PSN | 13 | ERYTHROMYCIN TABLETS, USP | 20181204 |
| ca1326d6-c5c6-4572-96b6-e56cd944799c | erythromycin 500 MG Oral Tablet | SCD | 13 | ERYTHROMYCIN TABLETS, USP | 20181204 |
| 933049f6-61b9-4ed5-b6b7-60c5037e2115 | erythromycin 500 MG Oral Tablet | SCD | 11 | Erythromycin Tablets, USP | 20260305 |
| 933049f6-61b9-4ed5-b6b7-60c5037e2115 | erythromycin 500 MG Oral Tablet | PSN | 11 | Erythromycin Tablets, USP | 20260305 |
| 3b415e31-e5d4-4990-8021-78459af73372 | erythromycin 500 MG Oral Tablet | PSN | 4 | Erythromycin Tablets, USP Rx only | 20251017 |
| 3b415e31-e5d4-4990-8021-78459af73372 | erythromycin 500 MG Oral Tablet | SCD | 4 | Erythromycin Tablets, USP Rx only | 20251017 |
| 0c05e1f7-a3d4-8e69-e063-6394a90aecc3 | erythromycin 500 MG Oral Tablet | SCD | 3 | Erythromycin Tablets, USP | 20260421 |
| 0c05e1f7-a3d4-8e69-e063-6394a90aecc3 | erythromycin 500 MG Oral Tablet | PSN | 3 | Erythromycin Tablets, USP | 20260421 |
| 75a0bd5a-d09f-483b-bfd8-f8343b149eb2 | erythromycin 500 MG Oral Tablet | SCD | 3 | ERYTHROMYCIN TABLETS, USP Rx only | 20240801 |
| 75a0bd5a-d09f-483b-bfd8-f8343b149eb2 | erythromycin 500 MG Oral Tablet | PSN | 3 | ERYTHROMYCIN TABLETS, USP Rx only | 20240801 |
| 0277341c-8513-4317-9334-c242f97630c1 | erythromycin 500 MG Oral Tablet | PSN | 3 | Erythromycin Tablets, USP | 20240320 |
| 0277341c-8513-4317-9334-c242f97630c1 | erythromycin 500 MG Oral Tablet | SCD | 3 | Erythromycin Tablets, USP | 20240320 |
| fae8fc38-3c60-43b8-a0f9-2c50df332505 | erythromycin 500 MG Oral Tablet | PSN | 3 | ERYTHROMYCIN TABLETS, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets and other antibacterial drugs, erythromycin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20231222 |
| fae8fc38-3c60-43b8-a0f9-2c50df332505 | erythromycin 500 MG Oral Tablet | SCD | 3 | ERYTHROMYCIN TABLETS, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets and other antibacterial drugs, erythromycin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20231222 |
| 383f9011-a3e0-4d7d-b058-5f8ab319dc8c | erythromycin 500 MG Oral Tablet | SCD | 3 | ERYTHROMYCIN TABLETS, USP Film-coated Tablets | 20230825 |
| 383f9011-a3e0-4d7d-b058-5f8ab319dc8c | erythromycin 500 MG Oral Tablet | PSN | 3 | ERYTHROMYCIN TABLETS, USP Film-coated Tablets | 20230825 |
| 379ed8f7-b54f-495f-932e-cd0e4c691134 | erythromycin 500 MG Oral Tablet | SCD | 3 | ERYTHROMYCIN TABLETS, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets and other antibacterial drugs, erythromycin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20210705 |
| 379ed8f7-b54f-495f-932e-cd0e4c691134 | erythromycin 500 MG Oral Tablet | PSN | 3 | ERYTHROMYCIN TABLETS, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets and other antibacterial drugs, erythromycin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20210705 |
| f2efbc94-64f7-4130-ab23-e5983854f730 | erythromycin 500 MG Oral Tablet | PSN | 3 | ERYTHROMYCIN TABLETS, USP | 20190114 |
| f2efbc94-64f7-4130-ab23-e5983854f730 | erythromycin 500 MG Oral Tablet | SCD | 3 | ERYTHROMYCIN TABLETS, USP | 20190114 |
| aa61cb37-5fc5-4225-b894-1d660386777f | erythromycin 500 MG Oral Tablet | PSN | 2 | ERYTHROMYCIN TABLETS, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets and other antibacterial drugs, erythromycin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20240109 |
| aa61cb37-5fc5-4225-b894-1d660386777f | erythromycin 500 MG Oral Tablet | SCD | 2 | ERYTHROMYCIN TABLETS, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets and other antibacterial drugs, erythromycin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20240109 |
| bc3d091b-1fc8-4f7a-a3c2-8ede87f5faa0 | erythromycin 500 MG Oral Tablet | SCD | 2 | ERYTHROMYCIN TABLETS, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets and other antibacterial drugs, erythromycin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20231223 |
| bc3d091b-1fc8-4f7a-a3c2-8ede87f5faa0 | erythromycin 500 MG Oral Tablet | PSN | 2 | ERYTHROMYCIN TABLETS, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets and other antibacterial drugs, erythromycin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20231223 |
| 76608fdd-1248-4942-9518-fd8076244fa7 | erythromycin 500 MG Oral Tablet | SCD | 2 | Erytrhomycin Tablets, USP | 20230621 |
| 76608fdd-1248-4942-9518-fd8076244fa7 | erythromycin 500 MG Oral Tablet | PSN | 2 | Erytrhomycin Tablets, USP | 20230621 |
| 3e823928-c853-4617-acad-21b27174aa7b | erythromycin 500 MG Oral Tablet | SCD | 2 | 20100729 | |
| 3e823928-c853-4617-acad-21b27174aa7b | erythromycin 500 MG Oral Tablet | PSN | 2 | 20100729 | |
| 904b9ab6-9a2a-47f3-8a38-04920ce696e0 | erythromycin 500 MG Oral Tablet | PSN | 1 | ERYTHROMYCIN TABLETS, USP Film-coated Tablets | 20230829 |
| 904b9ab6-9a2a-47f3-8a38-04920ce696e0 | erythromycin 500 MG Oral Tablet | SCD | 1 | ERYTHROMYCIN TABLETS, USP Film-coated Tablets | 20230829 |
| e83ebf1a-2719-4f52-a47d-3d5af9e8d6f4 | erythromycin 500 MG Oral Tablet | SCD | 1 | ERYTHROMYCIN Base Filmtab® (erythromycin tablets, USP) | 20101220 |
| e83ebf1a-2719-4f52-a47d-3d5af9e8d6f4 | erythromycin 500 MG Oral Tablet | PSN | 1 | ERYTHROMYCIN Base Filmtab® (erythromycin tablets, USP) | 20101220 |